Research graph
References from Evaluating periportal fibrosis in schistosomiasis mansoni using the ELF [Enhanced Liver Fibrosis] score: A pilot study. Local targets link to admitted publications; unresolved targets remain external evidence.
Review of 2022 WHO guidelines on the control and elimination of schistosomiasis
2022 · External reference
Schistosomiasis in America
10.1007/978-3-7091-1422-3_2 · 2015 · External reference
Challenges to schistosomiasis control program in Brazil: Setbacks in the control program and critical analysis of the disease notification
10.1590/0037-8682-0598-2023 · 2024 · External reference
Unresolved reference
2020 · External reference
Morbidity and mortality due to schistosoma mansoni related periportal fibrosis: Could early diagnosis of varices improve the outcome following available treatment modalities in Sub Saharan Africa? A scoping review
10.3390/tropicalmed5010020 · 2020 · External reference
Schistosomal hepatopathy
10.1590/s0074-02762004000900009 · 2004 · External reference
Human schistosomiasis
10.1016/s0140-6736(24)02814-9 · 2025 · External reference
Unresolved reference
1996 · External reference
The role of point-of-care ultrasound in the assessment of schistosomiasis-induced liver fibrosis: A systematic scoping review
10.1371/journal.pntd.0012033 · 2024 · External reference
Ultrasound in schistosomiasis mansoni
10.1590/s0074-02762010000400021 · 2010 · External reference
Ultrasound versus biological markers in the evaluation of periportal fibrosis in human Schistosoma mansoni
10.1590/s0074-02762011000700004 · 2011 · External reference
Noninvasive fibrosis testing in chronic liver disease including caveats
10.1016/j.cld.2022.08.008 · 2023 · External reference
Appraising diagnostic performance of ELF test by pathological staging and digital quantification of liver fibrosis
10.1016/j.aohep.2019.06.015 · 2019 · External reference
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
10.1053/jhep.2003.50346 · 2003 · External reference
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection
10.1002/hep.21178 · 2006 · External reference
FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest
10.1002/hep.21669 · 2007 · External reference
Serum markers detect the presence of liver fibrosis: A cohort study
10.1053/j.gastro.2004.08.052 · 2004 · External reference
Noninvasive diagnosis of periportal fibrosis in schistosomiasis mansoni: A comprehensive review
10.4254/wjh.v14.i4.696 · 2022 · External reference
Correlation between platelet count and both liver fibrosis and spleen diameter in patients with schistosomiasis mansoni
10.1590/s0004-28032014000100008 · 2014 · External reference
Correlation among three non-invasive methods (APRI, FIB-4 and transient elastography) to evaluate liver function and stiffness in patients with viral hepatitis C or schistosomiasis mansoni
10.5216/rpt.v47i2.53679 · 2018 · External reference
The Coutinho index as a simple tool for screening patients with advanced forms of Schistosomiasis mansoni: A validation study
10.1093/trstmh/trab040 · 2022 · External reference
Systematic review: Accuracy of the enhanced liver fibrosis test for diagnosing advanced liver fibrosis and cirrhosis
10.1111/jgh.15482 · 2021 · External reference
Enhanced liver fibrosis test for the non-invasive diagnosis of fibrosis in patients with NAFLD: A systematic review and meta-analysis
10.1016/j.jhep.2020.03.036 · 2020 · External reference
Report of the second satellite symposium on ultrasound in schistosomiasis
10.1590/s0074-02762001000900023 · 2001 · External reference
Performance of noninvasive tests of fibrosis among asians, hispanic, and non-hispanic whites in the STELLAR trials
10.1016/j.cgh.2022.01.015 · 2023 · External reference
Performance of the enhanced liver fibrosis test to estimate advanced fibrosis among patients with nonalcoholic fatty liver disease
10.1001/jamanetworkopen.2021.23923 · 2021 · External reference
Enhanced liver fibrosis score: Is it useful for evaluation of fibrosis severity in chronic hepatitis C infection?
2022 · External reference
Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease
10.1016/j.jhep.2021.05.037 · 2021 · External reference
Comparison of non-invasive clinical algorithms for liver fibrosis in patients with chronic hepatitis B to reduce the need for liver biopsy: application of enhanced liver fibrosis and Mac-2 binding protein glycosylation isomer
10.3343/alm.2022.42.2.249 · 2022 · External reference
Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease
10.1111/liv.14498 · 2020 · External reference
Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature
10.1371/journal.pntd.0009191 · 2021 · External reference
